Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA “Credibility,” “Authority” Threatened By State Imports, PhRMA Says

Executive Summary

FDA needs to take action against state and local governments that encourage drug importation, Pharmaceutical Research & Manufacturers of America Assistant General Counsel Scott Lassman told a Food & Drug Law Institute audioconference Dec. 16

You may also be interested in...

Rx Import Law Likely In ‘04, AARP’s Rother Says; FDA Thinks States Will Wait

Congress will pass prescription drug importation legislation in 2004 as a "bridge" to the Medicare drug benefit in 2006, AARP Policy & Strategy Director John Rother predicted during a Kaiser Family Foundation webcast Dec. 2

Reimportation Limits Remain In Medicare Agreement; HHS Study Requested

HHS would conduct a study of the safety issues associated with drug reimportation under the Medicare Rx benefit 1conference agreement released Nov. 20

Canadian Rx Import Business Is Illegal, Court Finds In Granting FDA Injunction

Rx Depot will be required to send a letter to customers indicating that the firm has violated the law under a Tulsa federal court order

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts